Filing Details

Accession Number:
0000950170-23-066901
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-30 08:00:04
Reporting Period:
2023-11-29
Accepted Time:
2023-11-30 08:00:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1833214 Sab Biotherapeutics Inc. SABS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1394645 J Samuel Reich 2100 E 54Th Street North
Sioux Falls SD 57104
Executive Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-29 11,000 $0.89 219,001 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 547,698 Indirect Via Big Cypress Holdings LLC
Footnotes
  1. Represents 11,000 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), acquired by the reporting person in an open market transaction.
  2. Includes 1,000 shares of Common Stock held jointly by the reporting person and the reporting person's spouse.